glp-1 malnutrition therapies are powerful, but they come with real risks that are often overlooked., Reduced appetite can lead to dehydration and if patients are not properly supported, especially in Malnutrition and Sarcopenia as Reasons

How do I switch

The current model is that when the DTC presenting LAG-2 and APX-1 interacts with GLP-1 expressed in germ cells, ligand dependent cleavage of the receptor generates the GLP-1 intracellular domain, GLP-1(ICD), which translocates to the nucleus and associates with the sequence specific DNA binding protein LAG-1 to activate primary target gene transcription

The European respiratory journal 2020;56

Compounded medications from licensed pharmacies use the same active molecule as branded drugs but are not FDA-approved for safety, efficacy, or quality

Supports appetite control and satiety as natural hunger returns